Phocas Financial Corp’s Amneal Pharmaceuticals AMRX Stock Holding History

Phocas Financial Corp’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.2M	Sell	819,476 -183,188	-18%	-$2.51M	1.97%	2
2026 Q1	$12.5M	Sell	1,002,664 -280,310	-22%	-$3.76M	1.96%	1
2025 Q4	$16.2M	Sell	1,282,974 -2,810	-0.2%	-$32.2K	2.1%	2
2025 Q3	$12.9M	Buy	1,285,784 +26,220	+2%	+$235K	1.67%	8
2025 Q2	$10.2M	Buy	1,259,564 +186	+0%	+$1.4K	1.47%	15
2025 Q1	$10.6M	Sell	1,259,378 -71,035	-5%	-$593K	1.62%	9
2024 Q4	$10.5M	Buy	+1,330,413	New	+$11.2M	1.41%	16
2023 Q4	$4.34M	Buy	+714,890	New	+$3.18M	0.57%	82
2019 Q2	–	Sell	-376,213	Closed	-$5.33M	–	323
2019 Q1	$5.33M	Buy	+376,213	New	+$4.97M	0.54%	83

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Phocas Financial Corp's AMRX Position: Q2 2026 in Review

Phocas Financial Corp reduced its Amneal Pharmaceuticals (AMRX) stake by 18% in Q2 2026, selling an estimated $2.51M and leaving 819,476 shares worth $14.2M. The position accounts for 1.97% of the portfolio, ranked #2.

Phocas Financial Corp first reported a position in AMRX in Q1 2019 and has held it in 9 quarters since. The position peaked at $16.2M in Q4 2025. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Phocas Financial Corp held 819,476 shares of Amneal Pharmaceuticals worth $14.2M as of Q2 2026.
Phocas Financial Corp sold 183,188 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.51M.
Amneal Pharmaceuticals made up 1.97% of Phocas Financial Corp's portfolio in Q2 2026, its #2 holding.
Phocas Financial Corp first reported a position in Amneal Pharmaceuticals in Q1 2019 and has held it in 9 quarters since.
Phocas Financial Corp's Amneal Pharmaceuticals position peaked at $16.2M in Q4 2025.
306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Phocas Financial Corp's 13F filing for Q2 2026, filed 31 Jul 2026.